Literature DB >> 11528555

Genetic analysis of childhood germ cell tumors with comparative genomic hybridization.

D T Schneider1, A E Schuster, M K Fritsch, G Calaminus, D Harms, U Göbel, E J Perlman.   

Abstract

BACKGROUND: Germ Cell Tumors (GCTs) in children and adolescents constitute a clinically and histologically heterogeneous group of tumors. Compared to GCTs in adults, the numbers of GCTs in children analyzed with cytogenetic and molecular genetic techniques is limited. However, the data available to date reveal a pattern of cytogenetic aberrations different from that in adults. Comparative genomic hybridization (CGH) is a valuable technique for the genetic profiling of tumors that allows screening for chromosomal imbalances consistent with amplification of oncogenes and loss of putative tumor suppressor genes. As CGH does not require tissue culture, it also allows analysing archival tissue samples. PATIENTS: This study focuses exclusively on GCTs in children younger than ten years of age and summarizes the genetic data of 51 tumors. Eighteen teratomas and 33 malignant GCTs were included. Primary sites were the testis (n=10), coccyx (n=13), mediastinum (n=20), ovary (n=5), CNS (n=2), and the face (n=1).
METHODS: The experimental procedure includes differential enzymatic fluorescence labeling of tumor and control DNA followed by comparative hybridization to normal male chromosomes, karyotyping and computerized analysis of the fluorescence profiles.
RESULTS: With the exception of one testicular and two ovarian tumors, malignant GCTs in children do not show chromosomal gain of 12p, which is characteristic of GCTs in adult patients. Irrespective of the primary site, childhood GCTs show chromosomal imbalances of chromosome 1 (loss of distal 1p, gain of 1q), deletion of 4q and 6q as well as gain of 20q at a high frequency.
CONCLUSIONS: These studies will help guiding further investigations elucidating the role of putative tumor suppressor genes at e.g. 1p36 and 6q. In addition, further studies incorporated in prospective therapeutic protocols are necessary to evaluate the prognostic relevance of specific genetic aberrations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11528555     DOI: 10.1055/s-2001-16852

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN: 0300-8630            Impact factor:   1.349


  9 in total

1.  Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

Authors:  Katherine Amps; Peter W Andrews; George Anyfantis; Lyle Armstrong; Stuart Avery; Hossein Baharvand; Julie Baker; Duncan Baker; Maria B Munoz; Stephen Beil; Nissim Benvenisty; Dalit Ben-Yosef; Juan-Carlos Biancotti; Alexis Bosman; Romulo Martin Brena; Daniel Brison; Gunilla Caisander; María V Camarasa; Jieming Chen; Eric Chiao; Young Min Choi; Andre B H Choo; Daniel Collins; Alan Colman; Jeremy M Crook; George Q Daley; Anne Dalton; Paul A De Sousa; Chris Denning; Janet Downie; Petr Dvorak; Karen D Montgomery; Anis Feki; Angela Ford; Victoria Fox; Ana M Fraga; Tzvia Frumkin; Lin Ge; Paul J Gokhale; Tamar Golan-Lev; Hamid Gourabi; Michal Gropp; Guangxiu Lu; Ales Hampl; Katie Harron; Lyn Healy; Wishva Herath; Frida Holm; Outi Hovatta; Johan Hyllner; Maneesha S Inamdar; Astrid Kresentia Irwanto; Tetsuya Ishii; Marisa Jaconi; Ying Jin; Susan Kimber; Sergey Kiselev; Barbara B Knowles; Oded Kopper; Valeri Kukharenko; Anver Kuliev; Maria A Lagarkova; Peter W Laird; Majlinda Lako; Andrew L Laslett; Neta Lavon; Dong Ryul Lee; Jeoung Eun Lee; Chunliang Li; Linda S Lim; Tenneille E Ludwig; Yu Ma; Edna Maltby; Ileana Mateizel; Yoav Mayshar; Maria Mileikovsky; Stephen L Minger; Takamichi Miyazaki; Shin Yong Moon; Harry Moore; Christine Mummery; Andras Nagy; Norio Nakatsuji; Kavita Narwani; Steve K W Oh; Sun Kyung Oh; Cia Olson; Timo Otonkoski; Fei Pan; In-Hyun Park; Steve Pells; Martin F Pera; Lygia V Pereira; Ouyang Qi; Grace Selva Raj; Benjamin Reubinoff; Alan Robins; Paul Robson; Janet Rossant; Ghasem H Salekdeh; Thomas C Schulz; Karen Sermon; Jameelah Sheik Mohamed; Hui Shen; Eric Sherrer; Kuldip Sidhu; Shirani Sivarajah; Heli Skottman; Claudia Spits; Glyn N Stacey; Raimund Strehl; Nick Strelchenko; Hirofumi Suemori; Bowen Sun; Riitta Suuronen; Kazutoshi Takahashi; Timo Tuuri; Parvathy Venu; Yuri Verlinsky; Dorien Ward-van Oostwaard; Daniel J Weisenberger; Yue Wu; Shinya Yamanaka; Lorraine Young; Qi Zhou
Journal:  Nat Biotechnol       Date:  2011-11-27       Impact factor: 54.908

Review 2.  Genomic instability in pluripotent stem cells: implications for clinical applications.

Authors:  Suzanne E Peterson; Jeanne F Loring
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 3.  Lessons from human teratomas to guide development of safe stem cell therapies.

Authors:  Justine J Cunningham; Thomas M Ulbright; Martin F Pera; Leendert H J Looijenga
Journal:  Nat Biotechnol       Date:  2012-09       Impact factor: 54.908

Review 4.  Testicular cancer.

Authors:  Liang Cheng; Peter Albers; Daniel M Berney; Darren R Feldman; Gedske Daugaard; Timothy Gilligan; Leendert H J Looijenga
Journal:  Nat Rev Dis Primers       Date:  2018-10-05       Impact factor: 52.329

5.  A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Authors:  C Krona; K Ejeskär; H Carén; F Abel; R-M Sjöberg; T Martinsson
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

Review 6.  Molecular characteristics of malignant ovarian germ cell tumors and comparison with testicular counterparts: implications for pathogenesis.

Authors:  Sigrid Marie Kraggerud; Christina E Hoei-Hansen; Sharmini Alagaratnam; Rolf I Skotheim; Vera M Abeler; Ewa Rajpert-De Meyts; Ragnhild A Lothe
Journal:  Endocr Rev       Date:  2013-04-10       Impact factor: 19.871

Review 7.  Recent Advancement of the Molecular Diagnosis in Pediatric Brain Tumor.

Authors:  Jeong-Mo Bae; Jae-Kyung Won; Sung-Hye Park
Journal:  J Korean Neurosurg Soc       Date:  2018-05-01

8.  Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology.

Authors:  Gabriele Calaminus; Dominik T Schneider; Dietrich von Schweinitz; Heribert Jürgens; Nacera Infed; Stefan Schönberger; Thomas A Olson; Peter Albers; Christian Vokuhl; Raimund Stein; Leendert Looijenga; Jalid Sehouli; Martin Metzelder; Alexander Claviez; Michael Dworzak; Angelika Eggert; Birgit Fröhlich; Nicolas U Gerber; Christian P Kratz; Jörg Faber; Thomas Klingebiel; Dieter Harms; Ulrich Göbel
Journal:  Cancers (Basel)       Date:  2020-03-06       Impact factor: 6.639

Review 9.  Biology of childhood germ cell tumours, focussing on the significance of microRNAs.

Authors:  M J Murray; J C Nicholson; N Coleman
Journal:  Andrology       Date:  2014-10-09       Impact factor: 3.842

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.